Table 7. Changes in symptom scores between groups.
Duration | Test (% difference) | Placebo (% difference) | p-value | |
---|---|---|---|---|
Digestive Behavior Score* (mean ± SD) | ||||
Baseline | 0.61 ± 0.99 | 0.48 ± 0.91 | 0.7039 | |
Day 30 | 0.13 ± 0.43 (78.69) | 0.52 ± 0.78 (8.33) | ||
Day 60 | 0.06 ± 0.25 (90.19) | 0.48 ± 0.83 (0) | ||
Day 90 | 0.00 ± 0.00 (100) | 0.41 ± 0.63 (14.58) | ||
Mean diff (Baseline – Day 30) | 0.48 ± 1.00 | −0.03 ± 0.82 | 0.0854 | |
Mean diff (Baseline – Day 60) | 0.55 ± 0.96 | 0.00 ± 0.60 | 0.0643 | |
Mean diff (Baseline – Day 90) | 0.61 ± 0.99 | 0.07 ± 0.88 | 0.0818 | |
p-value | 0.00007 | 0.9673 | ||
Sleep Quality Score† (mean ± SD) | ||||
Baseline | 7.77 ± 1.67 | 7.31 ± 1.00 | 0.2007 | |
Day 30 | 5.32 ± 1.28 (31.54) | 6.76 ± 0.95 (7.52) | ||
Day 60 | 5.23 ± 0.72 (32.69) | 7.10 ± 0.67 (2.87) | ||
Day 90 | 5.13 ± 0.72 (33.98) | 7.07 ± 0.88 (3.28) | ||
Mean diff (Baseline – Day 30) | 2.45 ± 1.75 | 0.55 ± 0.83 | < 0.001 | |
Mean diff (Baseline – Day 60) | 2.55 ± 1.61 | 0.21 ± 1.24 | < 0.001 | |
Mean diff (Baseline – Day 90) | 2.65 ± 1.85 | 0.24 ± 1.46 | < 0.001 | |
p-value | < 0.001 | 0.1318 |
*Data analyzed by Wilcoxan signed ranked test within groups and Mann Whitney U test between groups. Significant at p < 0.05.
†Data analyzed by Student’s t-test.